Bocco, Jose Luis
José Luis Bocco, PhD.
Jose Luis Bocco graduated as Biochemist in 1983 in the School of Chemistry, National University of Cordoba. He performed his doctoral studies in the same Institution at the Departamento de Bioquímica Clínica (Department of Clinical Biochemistry, nowadays also CIBICI) and obtained his PhD degree in 1989.
Between 1990 and 1993 he obtained a fellowship from the Association pour la Recherche contre le Cancer (Association for Cancer Research) to perform a post-doctoral training in Strasbourg, France, working on transcription regulation of gene expression by viral oncoproteins.
Since 1994, Jose Luis Bocco is a CONICET Investigator, currently “Superior Investigator”.
Between 2000 and 2009 he was designated Visitor Professor in the Louis Pasteur University, Strasbourg, France, participating in teaching activities at the École Supériuere de Biotechnologie de Strasbourg.
Also since 1994, he is a Professor at the Departamento de Bioquímica Clínica and his current position is Full Professor. Dr. Bocco has been the Director of seven doctoral thesis in the field of gene expression regulation and molecular microbiology, leading to the conformation of several independent groups in a variety of fields including oncogenesis, tumor suppressor genes, bacterial pathogenesis and molecular epidemiology of clinically relevant bacteria, yielding more than 50 peer-reviewed publications in good impact factor journals like PNAS, Oncogene, FASEB, The Journal of Biological Chemistry, Cell Death&Differentiation,Molecular and Cellular Biology, Journal of Clinical Microbiology, Mechanisms of Development, etc.
Since 2012 Dr. Bocco is a member of the Group of Investigators in Applied Research Projects BIOHEMO, involving CONICET and the Laboratorio de Hemoderivados- Universidad Nacional de Córdoba (Laboratory of Blood-derived products, National University of Cordoba), for the production of human coagulation factor IX through recombinant technology.
Since 2014 Dr. Bocco is the Principal Investigator of the multidisciplinary project PAE-GSK, funded by GlaxoSmithKline and MINCyT, which is aimed to identify new targets for anti-cancer drugs.
From 2010 to 2015, and again from 2015 to 2020, Dr. Bocco was designated as Chairman of CIBICI, position obtained by public contest in both opportunities.
Between 2013 and 2015, Dr. Bocco was designated as Director of the Centro Científico Tecnológico CONICET Córdoba (CCT-Cordoba) by peer vote among Directors of all the Research Institutes belonging to CONICET in the Córdoba region.
Dr. Bocco has published numerous peer-reviewed papers in prestigious journals. To see a detailed list of publications, please go to: